drugset / Trial / NCT05245448
Tetrandrine in the Treatment of Rheumatoid Arthritis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the efficacy and safety of tetrandrine, compared with placebo in 12 week or 24 week in RA patients with inadequate response to methotrexate.
Timeline
- Start
- 2022-02-22
- Primary completion
- 2023-10-30
- Completion
- 2024-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tetrandrine | Traditional medicine (herbal / TCM) | 40 mg | Oral |